Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Anteris Technologies Global Q3 2026 Results: Net Loss of $26.8M, Loss Widens

Anteris Technologies Global Corp. reported a net loss of $78.5 million for the nine months ended September 30, 2026, driven by significant research and development expenses of $62.2 million. The company's financial position improved substantially during the period, with cash and cash equivalents increasing to $232.8 million following the issuance of common stock, resulting in a total stockholders' equity of $226.8 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.50.4
Profit before tax-27.1-22.2
Net income-26.8-22.2
EPS (diluted, $ a share)$-0.28$-0.62

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+21.0%
Source

10-Q filed with the SEC, NASDAQ: AVR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Anteris Technologies Global Corp.: key numbers

Share price
$5.70Close, Nov 16
Market cap
$556M
Shares outstanding
97.49MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Anteris Technologies Global Corp.

All →
6:01 AM ET 8-K
Financial Results

Anteris Technologies Global Financial Results

Anteris Technologies Global Corp. reported its financial results for the third quarter ended September 30, 2026, filing its Form 10-Q with the SEC and providing supplementary disclosures for the Australian Securities Exchange (ASX). The company highlighted its ongoing development of the DurAVR THV biomimetic heart valve and disclosed $576,000 in payments to related parties, including executive salaries and director fees.

Term
Q3 2026
7:13 PM ET Form 4
Insider Buying

Anteris Technologies Global Insider L1 Capital Pty Ltd Buys $1.96M of Stock

L1 Capital Pty Ltd bought 272,695 shares of Anteris Technologies Global Corp. at $7.18 a share, worth $1.96M in total on Oct 6, 2026. Shares held after the trade: 6,358,271 (+4.5%).

Value
$1.96M
Shares
272,695
Price
$7.18
Holding change
+4.5%
Trade date
Oct 6, 2026
6:18 AM ET Form 4
Insider Buying

Anteris Technologies Global Insider L1 Capital Pty Ltd Buys $6.71M of Stock

L1 Capital Pty Ltd bought 884,809 shares of Anteris Technologies Global Corp. at $7.51 to $7.78 a share (average $7.58) in 2 transactions, worth $6.71M in total between Oct 2, 2026 and Oct 5, 2026. Shares held after the trade: 12,778,380 (+5.3%).

Value
$6.71M
Shares
884,809
Average price
$7.58
Holding change
+5.3%
Trade date
Oct 2, 2026 to Oct 5, 2026
8:09 PM ET Form 4
Insider Buying

Anteris Technologies Global Insider L1 Capital Pty Ltd Buys $3.03M of Stock

L1 Capital Pty Ltd bought 397,226 shares of Anteris Technologies Global Corp. at $7.60 to $7.72 a share (average $7.62) in 2 transactions, worth $3.03M in total between Sep 30, 2026 and Oct 1, 2026. Shares held after the trade: 5,200,767 (+6.6%).

Value
$3.03M
Shares
397,226
Average price
$7.62
Holding change
+6.6%
Trade date
Sep 30, 2026 to Oct 1, 2026
7:30 AM ET 8-K
Business Update

Anteris Technologies Global Business Update

Anteris Technologies Global Corp. entered into an amendment to its existing Supply & Quality Agreement with Harvey Industries Group Pty Ltd. The amendment extends the contract term until December 31, 2026, or until a new replacement agreement is executed, ensuring continued operational supply for the company's subsidiary.

Counterparty
Harvey Industries Group Pty Ltd
Term
through Dec 2026
5:01 PM ET 8-K
Stock Plan Amendment

Anteris Technologies Global Stock Plan Amendment

Anteris Technologies approved contingent equity grants for CEO Wayne Paterson (1,200,000 stock options and 800,000 PSUs) and David St Denis (414,000 stock options and 485,000 PSUs). The grants are subject to stockholder approval and feature a four-year vesting schedule tied to continuous employment and performance milestones.

Term
4 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.